Understanding the transcriptional regulation of cervix cancer using microarray gene expression data and promoter sequence analysis of a curated gene set

Gene

Volumn 535, Issue 2, 2014, Pages 233-238

  Srivastava, Prashant ^a   Mangal, Manu ^b   Agarwal, Subhash Mohan ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

CCDB; Cervical cancer; E2F; MARA; Microarray; Transcription factors

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CARCINOGENESIS; DOWN REGULATION; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

CANCEROUS INHIBITOR OF PROTEIN PHOSPHATASE 2A; CCDB; CERVICAL CANCER; CERVICAL CANCER GENE DATABASE; CIP2A; E2F; HPV; HUMAN PAPILLOMAVIRUS; MARA; MICROARRAY; MOTIF ACTIVITY RESPONSE ANALYSIS; TFBS; TFS; TRANSCRIPTION FACTOR BINDING SITE; TRANSCRIPTION FACTORS; TRANSCRIPTION START SITE; TSS;

BINDING SITES; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 84891148354     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.11.028     Document Type: Article

References (53)

1. Agarwal S.M. Evolutionary rate variation in eukaryotic lineage specific human intronless proteins. Biochem. Biophys. Res. Commun. 2005, 337:1192-1197.
2. Agarwal S.M., Gupta J. Comparative analysis of human intronless proteins. Biochem. Biophys. Res. Commun. 2005, 331:512-519.
3. Agarwal S.M., Raghav D., Singh H., Raghava G.P.S. CCDB: a curated database of genes involved in cervix cancer. Nucleic Acids Res. 2011, 39:D975-D979.
4. Arbyn M., et al. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 2011, 22:2675-2686.
5. Arvanitis D.A., Spandidos D.A. Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study. Oncol. Rep. 2008, 20:751-760.
6. Bachtiary B., et al. Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin. Cancer Res. 2006, 12:5632-5640.
7. Baritaki S., et al. Overexpression of VEGF and TGF-ß1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int. J. Oncol. 2007, 31:69-79.
8. Berezikov E., Guryev V., Plasterk R.H.A., Cuppen E. CONREAL: conserved regulatory elements anchored alignment algorithm for identification of transcription factor binding sites by phylogenetic footprinting. Genome Res. 2004, 14:170-178.
9. Bertino J.R., Banerjee D. E2F-1 as an anticancer drug target. Oncol. Rev. 2009, 3:207-214.
10. Biewenga P., et al. Gene expression in early stage cervical cancer. Gynecol. Oncol. 2008, 108:520-526.
11. Bulyk M.L. Computational prediction of transcription-factor binding site locations. Genome Biol. 2003, 5:201.
12. Chang K.-Y., et al. Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1 beta signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma. J. Biol. Chem. 2009, 284:9908-9916.
13. Chao A., et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int. J. Cancer 2006, 119:91-98.
14. Dohr S., Klingenhoff A., Maier H., de Angelis M.H., Werner T., Schneider R. Linking disease-associated genes to regulatory networks via promoter organization. Nucleic Acids Res. 2005, 33:864-872.
15. Dong X.-P., Stubenrauch F., Beyer-Finkler E., Pfister H. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int. J. Cancer 1994, 58:803-808.
16. Essack M., MacPherson C.R., Schmeier S., Bajic V.B. Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model. BMC Syst. Biol. 2012, 6:135.
17. Goodarzi H., Elemento O., Tavazoie S. Revealing global regulatory perturbations across human cancers. Mol. Cell 2009, 36:900-911.
18. He G., et al. YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide. Int. J. Gynecol. Cancer 2011, 21:1097-1104.
19. Hu Z., Gallo S.M. Identification of interacting transcription factors regulating tissue gene expression in human. BMC Genomics 2010, 11:49.
20. Ibraheem O., Botha C.E.J., Bradley G. In silico analysis of cis-acting regulatory elements in 5'regulatory regions of sucrose transporter gene families in rice (Oryza sativa japonica) and Arabidopsis thaliana. Comput. Biol. Chem. 2010, 34:268-283.
21. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
22. Karstensen B., Poppelreuther S., Bonin M., Walter M., Iftner T., Stubenrauch F. Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes. Virology 2006, 353:200-209.
23. Kaur M., MacPherson C.R., Schmeier S., Narasimhan K., Choolani M., Bajic V.B. In silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer. BMC Syst. Biol. 2011, 5:144.
24. Kim N.S., et al. Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers. Pathol. Oncol. Res. 2011, 17:493-502.
25. Lee E.-J., Jo M., Park J., Zhang W., Lee J.-H. Alternative splicing variants of IRF-1 lacking exons 7, 8, and 9 in cervical cancer. Biochem. Biophys. Res. Commun. 2006, 347:882-888.
26. Lutzner N., Arce J.D.-C., Rosl F. Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors. PLoS ONE 2012, 7:e32590.
27. Manavi M., Hudelist G., Fink-Retter A., Gschwandtler-Kaulich D., Pischinger K., Czerwenka K. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. Gynecol. Oncol. 2007, 105:418-426.
28. Massimi P., Pim D., Kuhne C., Banks L. Regulation of the human papillomavirus oncoproteins by differential phosphorylation. Mol. Cell. Biochem. 2001, 227:137-144.
29. May M., Dong X.-P., Beyer-Finkler E., Stubenrauch F., Fuchs P.G., Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 1994, 13:1460.
30. Merkulova T.I., et al. Bioinformatical and experimental approaches to investigation of transcription factor binding sites in vertebrate genes. Biochemistry (Mosc.) 2007, 72:1187-1193.
31. Molina-Privado I., et al. E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma. Cancer Res. 2009, 69:4052-4058.
32. Pallai R., Bhaskar A., Sodi V., Rice L.M. Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells. Transcription 2012, 3:323-335.
33. Pipinikas C.P., Nair S.B., Kirby R.S., Carter N.D., Fenske C.D. Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers 2007, 12:541-557.
34. Reimer D., et al. Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer. Ann. N. Y. Acad. Sci. 2007, 1091:270-281.
35. Rhodes D.R., et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9:166-180.
36. Roider H.G., Manke T., O'Keeffe S., Vingron M., Haas S.A. PASTAA: identifying transcription factors associated with sets of co-regulated genes. Bioinformatics 2009, 25:435-442.
37. Rosty C., et al. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene 2005, 24:7094-7104.
38. Sandelin A., Alkema W., Engstrom P., Wasserman W.W., Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004, 32:D91-D94.
39. Sandelin A., Wasserman W.W., Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 2004, 32:W249-W252.
40. Scotto L., et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 2008, 47:755-765.
41. Scotto L., et al. Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol. Cancer 2008, 7:58.
42. Shen Y., Li Y., Ye F., Wang F., Lu W., Xie X. Identification of suitable reference genes for measurement of gene expression in human cervical tissues. Anal. Biochem. 2010, 405:224-229.
43. Sherman B.T., et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007, 35:W169-W175.
44. Stephen A.L., Thompson C.H., Tattersall M.H., Cossart Y.E., Rose B.R. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int. J. Cancer 2000, 86:695-701.
45. Suzuki H., et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat. Genet. 2009, 41:553-562.
46. Tabach Y., et al. Wide-scale analysis of human functional transcription factor binding reveals a strong bias towards the transcription start site. PLoS ONE 2007, 2:e807.
47. Uhlen M., et al. Towards a knowledge-based human protein atlas. Nat. Biotechnol. 2010, 28:1248-1250.
48. Um S.-J., Rhyu J.-W., Kim E.-J., Jeon K.-C., Hwang E.-S., Park J.-S. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett. 2002, 179:205-212.
49. van der Watt P.J., Ngarande E., Leaner V.D. Overexpression of KpnB1 and KpnB2 importin proteins in cancer derives from deregulated E2F activity. PLoS ONE 2011, 6:e27723.
50. Widschwendter A., et al. DNA methylation in serum and tumors of cervical cancer patients. Clin. Cancer Res. 2004, 10:565-571.
51. Wong Y.-F., et al. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int. J. Cancer 2006, 118:2461-2469.
52. Yang W.-T., Zheng P.-S. Kruppel-like factor 4 function as a tumor suppressor in cervical carcinoma. Cancer 2012, 118:3691-3702.
53. Zhai Y., et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res. 2007, 67:10163-10172.